Company: KROS
Filing Date: 2025-08-28
Form Type: 8-K
Source: 0001664710-25-000078
Chunk: 0

Company: Keros Therapeutics, Inc.
Filing Date: 2025-08-28
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01 Regulation FD Disclosure.

On August 28, 2025, Keros Therapeutics, Inc. (the “ Company”) issued a press release announcing that Jasbir Seehra, the Company’s President and Chief Executive Officer, will participate in a fireside chat presentation at the 2025 Wells Fargo Healthcare Conference on Thursday, September 4, 2025 at 2:15 p. m. Eastern time, and a corporate presentation at the H. C. Wainwright 27th Annual Global Investment Conference on Tuesday, September 9, 2025 at 12:00 p. m. Eastern time. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

The information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”) or otherwise subject to the liabilities of that section. The information contained herein and in the accompanying exhibit is not incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.